Income Statement (TTM)
Yonghe Medical Group Co., Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,638 | 1,864 | 2,090 | 2,129 | 2,169 | 2,016 | 1,863 | 1,638 | 1,413 | 1,453 | 1,492 | 1,635 | 1,777 | 1,813 | 1,850 | 1,827 | 1,804 | 1,785 | 1,766 |
Change (%) | 13.79 | 12.12 | 1.88 | 1.84 | -7.04 | -7.57 | -12.09 | -13.75 | 2.82 | 2.74 | 9.54 | 8.71 | 2.04 | 2.00 | -1.22 | -1.24 | -1.07 | -1.08 | |
% of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
Cost Of Sales | 417 | 473 | 529 | 559 | 589 | 583 | 578 | 559 | 540 | 586 | 633 | 706 | 780 | 785 | 791 | 755 | 720 | 691 | 661 |
Change (%) | 13.44 | 11.84 | 5.67 | 5.37 | -0.88 | -0.89 | -3.29 | -3.40 | 8.57 | 7.89 | 11.64 | 10.43 | 0.68 | 0.67 | -4.45 | -4.66 | -4.13 | -4.31 | |
% of Revenue | 25.43 | 25.35 | 25.29 | 26.23 | 27.14 | 28.94 | 31.03 | 34.14 | 38.24 | 40.37 | 42.40 | 43.21 | 43.89 | 43.31 | 42.74 | 41.35 | 39.92 | 38.68 | 37.42 |
Gross Operating Profit | 1,222 | 1,392 | 1,561 | 1,571 | 1,580 | 1,433 | 1,285 | 1,079 | 873 | 866 | 860 | 928 | 997 | 1,028 | 1,059 | 1,072 | 1,084 | 1,095 | 1,105 |
Change (%) | 13.91 | 12.21 | 0.59 | 0.59 | -9.33 | -10.29 | -16.05 | -19.12 | -0.74 | -0.74 | 8.00 | 7.41 | 3.10 | 3.01 | 1.19 | 1.18 | 0.96 | 0.95 | |
% of Revenue | 74.57 | 74.65 | 74.71 | 73.77 | 72.86 | 71.06 | 68.97 | 65.86 | 61.76 | 59.63 | 57.60 | 56.79 | 56.11 | 56.69 | 57.26 | 58.65 | 60.08 | 61.32 | 62.58 |
SG&A | 942 | 1,118 | 1,295 | 1,307 | 1,320 | 1,236 | 1,152 | 1,088 | 1,024 | 1,110 | 1,196 | 1,308 | 1,419 | 1,384 | 1,349 | 1,268 | 1,188 | 1,133 | 1,079 |
Change (%) | 18.74 | 15.78 | 0.99 | 0.98 | -6.36 | -6.79 | -5.56 | -5.89 | 8.40 | 7.75 | 9.29 | 8.50 | -2.46 | -2.52 | -5.98 | -6.36 | -4.56 | -4.78 | |
% of Revenue | 57.48 | 59.98 | 61.94 | 61.40 | 60.88 | 61.33 | 61.84 | 66.44 | 72.50 | 76.43 | 80.16 | 79.98 | 79.82 | 76.31 | 72.93 | 69.42 | 65.82 | 63.49 | 61.12 |
R&D | 12 | 12 | 13 | 13 | 14 | 15 | 17 | 18 | 18 | 21 | 23 | 26 | 29 | 29 | 29 | 25 | 21 | 20 | 18 |
Change (%) | 2.94 | 2.86 | 6.61 | 6.20 | 8.76 | 8.05 | 5.56 | 5.27 | 11.88 | 10.62 | 13.96 | 12.25 | -1.02 | -1.04 | -12.95 | -14.88 | -7.93 | -8.62 | |
% of Revenue | 0.72 | 0.65 | 0.60 | 0.63 | 0.65 | 0.76 | 0.89 | 1.07 | 1.31 | 1.42 | 1.53 | 1.60 | 1.65 | 1.60 | 1.55 | 1.37 | 1.18 | 1.10 | 1.01 |
OpEx | 1,368 | 1,598 | 1,828 | 1,873 | 1,918 | 1,828 | 1,738 | 1,656 | 1,574 | 1,713 | 1,851 | 2,043 | 2,235 | 2,204 | 2,173 | 2,050 | 1,926 | 1,841 | 1,756 |
Change (%) | 16.85 | 14.42 | 2.45 | 2.39 | -4.68 | -4.91 | -4.72 | -4.96 | 8.79 | 8.08 | 10.37 | 9.39 | -1.38 | -1.40 | -5.68 | -6.02 | -4.42 | -4.63 | |
% of Revenue | 83.48 | 85.72 | 87.48 | 87.97 | 88.45 | 90.69 | 93.30 | 101.12 | 111.43 | 117.90 | 124.02 | 124.96 | 125.74 | 121.53 | 117.49 | 112.19 | 106.76 | 103.14 | 99.45 |
Operating Income | 271 | 266 | 262 | 256 | 250 | 188 | 125 | -18 | -161 | -260 | -359 | -408 | -457 | -390 | -324 | -223 | -122 | -56 | 10 |
Change (%) | -1.67 | -1.70 | -2.13 | -2.18 | -25.07 | -33.45 | -114.64 | 783.29 | 61.03 | 37.90 | 13.80 | 12.12 | -14.64 | -17.15 | -31.15 | -45.25 | -54.00 | -117.38 | |
% of Revenue | 16.52 | 14.28 | 12.52 | 12.03 | 11.55 | 9.31 | 6.70 | -1.12 | -11.43 | -17.90 | -24.02 | -24.96 | -25.74 | -21.53 | -17.49 | -12.19 | -6.76 | -3.14 | 0.55 |
Interest Expense | -36 | -40 | -43 | -47 | -52 | -54 | -56 | -54 | -51 | -51 | -52 | -53 | -54 | -51 | -48 | -45 | -41 | -37 | -32 |
Change (%) | 9.19 | 8.42 | 10.46 | 9.47 | 4.35 | 4.17 | -4.64 | -4.87 | 0.39 | 0.39 | 2.46 | 2.40 | -5.56 | -5.89 | -7.19 | -7.75 | -10.78 | -12.08 | |
% of Revenue | -2.21 | -2.13 | -2.06 | -2.23 | -2.40 | -2.69 | -3.03 | -3.29 | -3.63 | -3.54 | -3.46 | -3.24 | -3.05 | -2.82 | -2.60 | -2.45 | -2.28 | -2.06 | -1.83 |
Net Income | 163 | 151 | 138 | 129 | 120 | 109 | 97 | 6 | -86 | -208 | -330 | -438 | -546 | -503 | -459 | -343 | -226 | -143 | -60 |
Change (%) | -7.66 | -8.29 | -6.55 | -7.01 | -9.49 | -10.49 | -94.09 | -1,590.85 | 141.99 | 58.68 | 32.87 | 24.74 | -8.02 | -8.72 | -25.33 | -33.93 | -36.78 | -58.17 | |
% of Revenue | 9.97 | 8.09 | 6.62 | 6.07 | 5.54 | 5.40 | 5.23 | 0.35 | -6.08 | -14.30 | -22.09 | -26.79 | -30.74 | -27.71 | -24.80 | -18.75 | -12.54 | -8.02 | -3.39 |
Source: Capital IQ